Tang Xiao-Da
Department of Urology, First People's Hospital, Shanghai Jiao Tong University, Shanghai 200080, China.
Zhonghua Nan Ke Xue. 2003 Sep;9(6):403-6.
Chronic prostatitis (CP)/chronic pelvic pain syndrome (CPPS) is a common problem of medically controversial condition that causes considerable morbidity and impact on life. Although there are many competing causes proposed, the etiology and pathogenesis of CP/CPPS remain unclear. The causative factors underlying the CPPS are not fully understood. The optimal management of CP/CPPS is still unknown. The guideline of diagnosis and management of CP/CPPS based on evidence base medicine is not yet established. Many problems are still not resolved, such as the significance of leukocytes and the role of inflammation in CP/CPPS, the significance of bacteria presence and the role of infection in CP/CPPS, the correlation between leukocytes/bacteria and severity of symptoms, how to divide the subgroups of CP/CPPS, the role of antimicrobial therapy in the treatment of men with CP/CPPS, why patients with category IIIb complain of symptoms, while those with category IV complain of none. Although CP/CPPS is now achieving greater recognition, well-designed studies with large sample size should be performed.
慢性前列腺炎(CP)/慢性盆腔疼痛综合征(CPPS)是一种在医学上存在争议的常见病症,会导致相当高的发病率并对生活产生影响。尽管提出了许多相互竞争的病因,但CP/CPPS的病因和发病机制仍不清楚。CPPS的致病因素尚未完全了解。CP/CPPS的最佳治疗方法仍然未知。基于循证医学的CP/CPPS诊断和治疗指南尚未建立。许多问题仍未得到解决,例如白细胞在CP/CPPS中的意义以及炎症的作用、细菌存在的意义以及感染在CP/CPPS中的作用、白细胞/细菌与症状严重程度之间的相关性、如何划分CP/CPPS的亚组、抗菌治疗在CP/CPPS男性患者治疗中的作用、为什么Ⅲb类患者会出现症状,而Ⅳ类患者却没有症状。尽管CP/CPPS现在越来越受到认可,但仍应开展设计良好的大样本研究。